{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:58:50Z","timestamp":1790650730463,"version":"4.1.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1095,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis (SS) to nonalcoholic steatohepatitis (NASH). Though liver-related risk seems confined to NASH, it is currently unclear whether NASH has a higher risk of cardiovascular disease (CVD) and diabetes than SS as a result of the coexistence of obesity and other cardiometabolic confounders. Adipose tissue is an emerging modulator of liver disease in NAFLD and of cardiometabolic disease in the general population. We evaluated in SS and NASH (1) glucose homeostasis and cardiovascular risk profile and (2) the effect of adipose tissue dysfunction, assessed in fasting conditions and postprandially, on liver injury, glucose and lipoprotein metabolism, and markers of early atherosclerosis. Forty nonobese, nondiabetic, normolipidemic biopsy-proven NAFLD patients (20 with SS and 20 with NASH) and 40 healthy subjects, matched for overall\/abdominal adiposity and metabolic syndrome, underwent an oral fat load test, with measurement of plasma triglyceride-rich lipoproteins, oxidized low-density lipoproteins, adipokines, and cytokeratin-18 fragments, and an oral glucose tolerance test with minimal model analysis to yield glucose homeostasis parameters. Circulating endothelial adhesion molecules were measured, and adipose tissue insulin resistance (adipose IR) index and visceral adiposity index were calculated. Despite similar fasting values, compared to SS, NASH showed a more atherogenic postprandial lipoprotein profile, an altered adipokine response (i.e., higher resistin increase and an adiponectin fall), and hepatocyte apoptosis activation after fat ingestion. Adipose IR index, endothelial adhesion molecules, and hepatic insulin resistance progressively increased across NAFLD stages. NASH, but not SS, showed an impaired pancreatic \u03b2-cell function. On multiple regression analysis, adipose IR index and postprandial adiponectin independently predicted liver histology and altered cardiometabolic parameters.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion:\n                                 <\/jats:bold>\n                                 <jats:bold>Adipose tissue dysfunction, including a maladaptive adipokine response to fat ingestion, modulates liver injury and cardiometabolic risk in NAFLD.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.25739","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T13:51:12Z","timestamp":1339163472000},"page":"933-942","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":112,"title":["Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism"],"prefix":"10.1097","volume":"56","author":[{"given":"Giovanni","family":"Musso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cassader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"De Michieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriano","family":"Rosina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gambino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20250207","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLDNASH based on the EASL 2009 special conference.","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"key":"R2-17-20250207","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1467-789X.2009.00657.x","article-title":"Nonalcoholic fatty liver disease from pathogenesis to management: an update.","volume":"11","author":"Musso","year":"2010","journal-title":"Obes Rev"},{"key":"R3-17-20250207","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Metaanalysis: natural history of nonalcoholic fatty liver disease (NAFLD) and diagnostic accuracy of noninvasive tests for liver disease severity.","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"key":"R4-17-20250207","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.","volume":"48","author":"van der Poorten","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R5-17-20250207","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepaticvisceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"key":"R6-17-20250207","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1440-1746.2007.05212.x","article-title":"Visceral adipose tissue area is an independent risk factor for hepatic steatosis.","volume":"23","author":"Park","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R7-17-20250207","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/aje\/kwh004","article-title":"Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of CancerNorfolk study.","volume":"159","author":"Harding","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R10-17-20250207","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/hep.23859","article-title":"Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1.","volume":"52","author":"Petta","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R11-17-20250207","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Nonalcoholic steatohepatitis: definition and pathology.","volume":"21","author":"Brunt","year":"2001","journal-title":"Semin Liver Dis"},{"key":"R12-17-20250207","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease.","volume":"41","author":"Kleiner","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R13-17-20250207","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1373\/clinchem.2006.081257","article-title":"Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease.","volume":"53","author":"Chang","year":"2007","journal-title":"Clin Chem"},{"key":"R14-17-20250207","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00005768-199704000-00015","article-title":"Bioimpedance analysis: evaluation of legtoleg system based on pressare contact footpad electrodes.","volume":"29","author":"Nunez","year":"1997","journal-title":"Med Sci Sports Exerc"},{"key":"R15-17-20250207","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.ijo.0802563","article-title":"Generalized abdominal visceral fat prediction models for black and white adults aged 17-65 y: the Heritage Family study.","volume":"28","author":"Stanforth","year":"2004","journal-title":"Intern J Obes"},{"key":"R16-17-20250207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in nonalcoholic fatty liver disease (NAFLD).","volume":"48","author":"Musso","year":"2009","journal-title":"Prog Lipid Res"},{"key":"R17-17-20250207","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/hep.22659","article-title":"Transcription factor 7like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH.","volume":"49","author":"Musso","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R18-17-20250207","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","article-title":"Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.","volume":"351","author":"Ridker","year":"1998","journal-title":"Lancet"},{"key":"R19-17-20250207","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.coph.2006.01.001","article-title":"Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.","volume":"6","author":"Pacher","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"R20-17-20250207","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1089\/ars.2009.3058","article-title":"Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.","volume":"15","author":"Gambino","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"R21-17-20250207","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.amjcard.2007.03.107","article-title":"Postprandial hyperglycemiahyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor.","volume":"100","author":"OKeefe","year":"2007","journal-title":"Am J Cardiol"},{"key":"R22-17-20250207","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","article-title":"A modelbased method for assessing insulin sensitivity from the oral glucose tolerance test.","volume":"24","author":"Mari","year":"2001","journal-title":"Diabetes Care"},{"key":"R23-17-20250207","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc06-1519","article-title":"Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.","volume":"30","author":"AbdulGhani","year":"2007","journal-title":"Diabetes Care"},{"key":"R24-17-20250207","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jnutbio.2009.06.007","article-title":"Lipoprotein metabolism mediates the association of MTP polymorphism with betacell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis.","volume":"21","author":"Musso","year":"2010","journal-title":"J Nutr Biochem"},{"key":"R25-17-20250207","doi-asserted-by":"crossref","first-page":"E1E15","DOI":"10.1152\/ajpendo.00421.2006","article-title":"Assessment of betacell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests.","volume":"293","author":"Cobelli","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R26-17-20250207","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.diabres.2005.10.005","article-title":"Insulinogenic indices from insulin and Cpeptide: comparison of betacell function from OGTT and IVGTT.","volume":"72","author":"Tura","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"R27-17-20250207","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man.","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"key":"R28-17-20250207","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2337\/diabetes.54.3.795","article-title":"Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B100 kinetics?","volume":"54","author":"Ng","year":"2005","journal-title":"Diabetes"},{"key":"R29-17-20250207","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ajcn\/78.6.1135","article-title":"Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus.","volume":"78","author":"Esposito","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"R30-17-20250207","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.metabol.2009.08.020","article-title":"Type 2 diabetes mellitus is characterized by reduced postprandial adiponectin response: a possible link with diabetic postprandial dyslipidemia.","volume":"59","author":"Annuzzi","year":"2010","journal-title":"Metabolism"},{"key":"R31-17-20250207","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1006\/bbrc.2001.5904","article-title":"Secretion of adiponectin and regulation of apM1 gene expression in human visceral abdominal tissue.","volume":"288","author":"Halleux","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R32-17-20250207","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/oby.2005.62","article-title":"Insulin and endothelin in the acute regulation of adiponectin in vivo in humans.","volume":"13","author":"Brame","year":"2005","journal-title":"Obes Res"},{"key":"R33-17-20250207","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1080\/00365510410007053","article-title":"Effects of a 3day low fat diet on metabolic control, insulin sensitivity, lipids, and lipoprotein hormones in Norwegian subjects with hypertriacylglycerolemia and type 2 diabetes.","volume":"64","author":"Mostad","year":"2004","journal-title":"Scand J Clin Lab Invest"},{"key":"R34-17-20250207","doi-asserted-by":"crossref","first-page":"22108","DOI":"10.1074\/jbc.M400238200","article-title":"Adipocyte determination and differentiationdependent factor 1sterol regulatory elementbinding protein 1c regulates mouse adiponectin expression.","volume":"279","author":"Seo","year":"2004","journal-title":"J Biol Chem"},{"key":"R35-17-20250207","first-page":"95","article-title":"Postprandial activation of protein kinase C regulates the expression of adipocytokines via the transcription factor AP2.","volume":"28","author":"Kondo","year":"2011","journal-title":"Int J Mol Med"},{"key":"R36-17-20250207","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bbrc.2010.01.056","article-title":"Transcription factor AP2beta: a negative regulator of IRS1 gene expression.","volume":"392","author":"Meng","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R37-17-20250207","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1210\/en.2009-1501","article-title":"Peroxisome proliferatoractivated receptorgamma increases adiponectin secretion via transcriptional repression of endoplasmic reticulum chaperone protein ERp44.","volume":"151","author":"Long","year":"2010","journal-title":"Endocrinology"},{"key":"R38-17-20250207","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.numecd.2010.10.012","article-title":"From chronic overfeeding to hepatic injury: role of endoplasmic reticulum stress and inflammation.","volume":"21","author":"Mollica","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R39-17-20250207","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/ATVBAHA.110.207373","article-title":"Effects of highdensity lipoproteins on pancreatic betacell insulin secretion.","volume":"30","author":"Fryirs","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R40-17-20250207","doi-asserted-by":"crossref","first-page":"E255E262","DOI":"10.1152\/ajpendo.00416.2010","article-title":"Lipidinduced pancreatic cell dysfunction: focus on in vivo studies.","volume":"300","author":"Giacca","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R42-17-20250207","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbrc.2006.02.032","article-title":"Adaptive failure to highfat diet characterizes steatohepatitis in Alms1 mutant mice.","volume":"342","author":"Arsov","year":"2006","journal-title":"Biochem Biophys Res Comm"},{"key":"R43-17-20250207","doi-asserted-by":"crossref","first-page":"34139","DOI":"10.1074\/jbc.M704896200","article-title":"Resistin is a key mediator of glucosedependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes.","volume":"282","author":"Kim","year":"2007","journal-title":"J Biol Chem"},{"key":"R44-17-20250207","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/hep.23116","article-title":"Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.","volume":"50","author":"Gastaldelli","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R45-17-20250207","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2010.06.033","article-title":"Newly appreciated therapeutic effect of GLP1 receptor agonists: reduction in postprandial lipemia.","volume":"212","author":"Bandsma","year":"2010","journal-title":"Atherosclerosis"},{"key":"R46-17-20250207","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.24070","article-title":"Need for a threefocused approach to nonalcoholic fatty liver disease.","volume":"53","author":"Musso","year":"2011","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25739","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201209000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:50:58Z","timestamp":1738947058000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201209000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25739","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}